Global Amebocyte Lysate Market Was Experienced With 9.89% Average Growth Rate In Several Years
Wednesday, 07 Nov, 2018
In the last several years, Global market of Amebocyte Lysate was experienced an upward trend rapidly, with an average growth rate of 9.89%. In 2016, Global Revenue of Amebocyte Lysate is nearly 285 M USD; the actual sales are about 43 M Doses.
China market of Amebocyte Lysate was experienced an upward trend rapidly, with an average growth rate of 13.64%. In 2016, China Revenue of Amebocyte Lysate is nearly 15 M USD; the actual sales are about 6.4 M Doses
The global average price of Amebocyte Lysate is is stable, from 6.80 USD/Dose in 2012 to 6.64 USD/Dose t in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Amebocyte Lysate includes Limulus Amebocyte Lysate and Tachypleus Amebocyte Lysate. The proportion of Limulus Amebocyte Lysate in 2016 is about 76%, and the proportion is in decreasing trend from 2012 to 2016.
Amebocyte Lysate is widely used in Drug?Testing, Clinical?Diagnosis and other field. The most proportion of Amebocyte Lysate is Drug?Testing, and the proportion in 2016 is 52%. The trend of Drug?Testing is stable.
Europe is the largest supplier of Amebocyte Lysate, with a production market share nearly 50% in 2016. United States is the second largest supplier of Amebocyte Lysate, enjoying production market share nearly 25% in 2016.
United States is the largest consumption place, with a consumption market share nearly 36% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is not intense. LONZA, Charles River Laboratories and Associates of Cape Cod are the leaders of the industry.